The largest community of pharma leaders

Intersect ENT Announces Appointment of Thomas A. West as CEO

MENLO PARK, Calif.–(BUSINESS WIRE)–Intersect ENT®, Inc. (Nasdaq:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the appointment of Thomas (“Tom”) A. West as President and Chief Executive Officer, effective July 22, 2019. He will also join the Intersect ENT Board of Directors at that time, and Kieran Gallahue will remain in his role as Executive Chairman of the Board. Mr. West has served as Division President, Diagnostics…

Recent Articles